What Should I Ask a Lawyer Before Signing a SAFE?

Short answer: Before signing a SAFE, ask a lawyer to walk through conversion, valuation-cap and discount mechanics, pro rata rights, dilution, governing law, investor information rights, and what happens in unusual financing or exit scenarios. The goal is not to turn a founder into a securities lawyer. It is to understand what ownership and flexibility the document may create before the signature becomes difficult to unwind.

What the question is really asking

This question is really about the gap between a short document and a long-lived economic consequence. A SAFE can feel simple because it does not set a priced-round valuation today, but its terms can affect who owns what after a later financing.

Use the legal meeting to translate each clause into a concrete scenario. Ask what the clause means if the next round is higher than expected, lower than expected, delayed, never happens, or is replaced by an acquisition or shutdown.

Treat the article as a working memo rather than a universal rule. Write down the current facts, the unresolved risk, the decision the company is facing, and the evidence that would change your mind. That habit keeps a founder from confusing a familiar financing pattern with a fit-for-purpose answer. It also makes the next conversation more productive because the open question is visible instead of buried in a polished story.

1. Confirm the instrument and governing law

Ask which SAFE form is being used, which version and jurisdiction govern, and whether any side letter, most-favored-nation right, or investor-specific amendment changes the standard terms.

2. Model conversion scenarios

Request a simple ownership model for a future priced round at several valuations. Include the purchase amount, cap, discount, existing shares, option pool, and any other SAFEs or notes.

3. Ask about pro rata and information rights

Clarify whether the investor can participate in later rounds, what notice or allocation process applies, and what information the company must provide before and after conversion.

4. Understand edge cases

Ask what happens if the company raises a small round, raises debt, sells, dissolves, or does not raise again. A document should be understandable in the paths you hope will not happen.

5. Check consistency across instruments

If there are multiple SAFEs, compare caps, discounts, side letters, and pro rata rights. The order and interaction of these instruments can change the eventual ownership math.

6. Clarify what is not promised

A SAFE is not a guarantee of a future valuation, liquidity, or investor support. Ask which risks remain with the company and which representations you are making in the document.

Worked example: turn legal questions into a scenario memo

Imagine a founder is considering a $300,000 post-money SAFE with a $6 million cap and a 20% discount. The company already has $200,000 of earlier SAFEs and expects to raise a priced round in 12 months. The founder should not evaluate the new SAFE in isolation.

Ask counsel to model a priced round at $5 million, $8 million, and $15 million post-money equivalents, and to show the effect of the earlier instruments, the option pool, and any pro rata participation. The numbers are illustrative, not a prediction or legal conclusion.

The output of the meeting should be a short decision memo: what the SAFE does, which assumptions drive conversion, what the founder is giving up, what remains uncertain, and which questions must be answered before signing.

Founder decision

Send counsel the current cap table and every prior financing document before the meeting. Leave with a plain-language summary and a list of terms you would change or accept. If you cannot explain the main conversion paths to a cofounder, you are not finished reviewing.

When not to follow this advice

Do not rely on a blog post, a template, or an investor’s explanation as a substitute for counsel reviewing your actual documents. Do not sign under artificial urgency if material questions are unanswered. If the economics do not fit, raise less, use another instrument, bootstrap, or wait.

Questions to resolve before signing

Ask how the SAFE converts if the next round is delayed, whether a cap and discount interact, and which capitalization definition the document uses. Request a simple example showing the investor shares, founder shares, option pool, and remaining ownership. If the example cannot be reconciled to the spreadsheet, the financing is not yet clear enough to sign.

Also compare the SAFE with raising less, waiting for more evidence, or using a priced round. A familiar instrument can still create an ownership transfer that is too large for the milestone it funds. The founder decision is not simply whether the terms are common; it is whether the capital buys enough progress to justify the transfer.

A useful next step

If you want a structured outside read, use the SAFE + Dilution Decoder. It is free, runs in your browser, and is designed to clarify the next decision rather than replace professional advice.

Related reading

Pair this with What Is a SAFE Agreement? and What Is Pro Rata in a SAFE?.

Disclosure: This is general educational information for founders, not legal, tax, accounting, investment, or financial advice. Illustrative numbers are examples only.